AUM Biosciences Competitors and Similar CompaniesClear all

AUM Biosciences's competitors and similar companies include Flare Therapeutics, Cleara Biotech, Gracell and Shanghai Junshi Biosciences.

	AUM Biosciences AUM Biosciences is an oncology-focused biotechnology company.	Flare Therapeutics Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer.	Cleara Biotech Cleara Biotech is a company engaged in the creation of therapeutics targeting age-related pathologies and therapy-resistant cancer.	Gracell Gracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer.	Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date	Founding Date 2018	Founding Date 2021	Founding Date 2018	Founding Date 2017	Founding Date 2012
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Singapore, SG HQ Collingwood, AU Singapore, SG Wilmington, US	Locations Cambridge, US HQ	Locations Utrecht, NL HQ	Locations Suzhou, CN HQ	Locations Shanghai, CN HQ
Employees	Employees 18	Employees 562% increase	Employees 13	Employees 314	Employees 2,9617% increase
Twitter followers	Twitter followers 310	Twitter followers 73	Twitter followers 225	Twitter followers N/A	Twitter followers N/A
Employee Rating	Employee Rating 2.3	Employee Rating N/A	Employee Rating N/A	Employee Rating N/A	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥1.2b (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥504.3m (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥938.8m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income (¥607.5m) (FY, 2022)	Net income (¥2.6b) (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 82m	Total funding raised N/A	Total funding raised $ 185m	Total funding raised N/A